Stuka Paul 4

What Happened
Paul Stuka, a director of InspireMD, acquired a total of 15,000 common shares in two open‑market purchases: 10,000 shares reported at $1.16 (total $11,575) on 2026-05-13 and 5,000 shares at $1.15 (total $5,750) on 2026-05-14, for combined consideration of $17,325. The transactions were disclosed on a Form 4 filed 2026-05-15.

Key Details

• Transaction dates and amounts: 2026-05-13 — 10,000 shares @ $1.16 (reported total $11,575); 2026-05-14 — 5,000 shares @ $1.15 (reported total $5,750).
• Footnote on price: filing notes a weighted‑average price and that purchases occurred at prices ranging $1.1550–$1.1599.
• Holdings after transaction: the filing does not state total shares beneficially owned after these purchases.
• Footnote on ownership: some securities in the filing are held by Osiris Investment Partners, L.P.; Stuka is the managing member of the general partner and may be deemed to beneficially own such securities but disclaims ownership except to his pecuniary interest. The filing also states no transaction was effected by Stuka with respect to those Osiris-held securities — they are included for informational purposes.
• Filing timeliness: Form 4 was filed 2026-05-15 covering 2026-05-13 and 2026-05-14 trades; the report appears to have been filed within the normal reporting window.

Context
These are outright purchases (insider buys), which many investors view as a stronger informational signal than routine sales. The filing includes clarifying footnotes about weighted prices and institutional holding via Osiris; no options, grants, gifts, or tax‑withholding events are involved in these reported transactions.